In vitro drug causality assessment in Stevens-Johnson syndrome - alternatives for lymphocyte transformation test.
about
In vitro Models to Evaluate Drug-Induced Hypersensitivity: Potential Test Based on Activation of Dendritic CellsToxic epidermal necrolysisPathogenesis and diagnosis of delayed-type drug hypersensitivity reactions, from bedside to bench and backDrug-specific upregulation of CD137 on CD8+ T cells aids in the diagnosis of multiple antibiotic toxic epidermal necrolysis.In Vitro Diagnostic Testing for Antibiotic AllergyLamotrigine-induced toxic epidermal necrolysis confirmed by in vitro granulysin and cytokine assays.Approach to the diagnosis of drug hypersensitivity reactions: similarities and differences between Europe and North America.The lymphocyte transformation test in allergic contact dermatitis: New opportunities.Drug hypersensitivity in children: report from the pediatric task force of the EAACI Drug Allergy Interest Group.Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: An Update.Adverse cutaneous drug eruptions: current understanding.In Vitro Assays in Severe Cutaneous Adverse Drug Reactions: Are They Still Research Tools or Diagnostic Tests Already?Old dog begging for new tricks: current practices and future directions in the diagnosis of delayed antimicrobial hypersensitivity.U.K. guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in adults 2016.Recent advances in the understanding of severe cutaneous adverse reactions.Precision medicine in allergic disease-food allergy, drug allergy, and anaphylaxis-PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma and Immunology.Evolution of diagnostic approaches in betalactam hypersensitivity.Severe Delayed Cutaneous and Systemic Reactions to Drugs: A Global Perspective on the Science and Art of Current Practice.The Value of In Vitro Tests to DiminishDrug Challenges.In vitro tests for drug hypersensitivity reactions: an ENDA/EAACI Drug Allergy Interest Group position paper.Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Associations, Outcomes, and Pathobiology-Thirty Years of Progress but Still Much to Be Done.Multiple Drug Hypersensitivity.Development of a modified lymphocyte transformation test for diagnosing drug-induced liver injury associated with an adaptive immune response.A pilot study evaluating biomarker development for drug-induced chronic eczematous eruptions of aging individuals.Current Perspectives on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.The Combined Utility of Ex vivo IFN-γ Release Enzyme-Linked ImmunoSpot Assay and In vivo Skin Testing in Patients With Antibiotic-Associated Severe Cutaneous Adverse Reactions.T-cell activation in two cases of Stevens-Johnson syndrome after receiving amoxicillin-clavulanic acid.Salazosulfapyridine-related Stevens-Johnson Syndrome Caused by Sulfapyridine and Confirmed by Enzyme-Linked Immunospot Assay.CME Part 1: Hair disorders in cancer patients.An annexin A1-FPR1 interaction contributes to necroptosis of keratinocytes in severe cutaneous adverse drug reactions.Vancomycin-Induced Stevens-Johnson Syndrome in a Boy Under 2 Years Old: An Early Diagnosis by Granulysin Rapid Test.Successful dabrafenib transition after vemurafenib-induced toxic epidermal necrolysis in a patient with metastatic melanoma
P2860
Q26741420-0A4E95E0-A8BB-4FD3-B10C-2E063AD793DFQ26745232-10F96E74-E351-4E2B-8FDB-E277430BCDB4Q26784638-7CB6AEE6-5CEF-4D24-95CA-2AEC6120ECF5Q33703420-BBCF448D-16D2-43A2-95DC-C0E12798907AQ33734324-A41995D5-9905-4040-8D4D-A48ACF0FB400Q34432051-92FB99C2-7886-4225-8853-7EFB4A683774Q37695437-A18CCC2D-9EE7-49C7-86A2-48AAC872CD80Q38345368-BB1268B6-09FC-48F6-968A-924A5CF8B99DQ38594812-7B1C6DAE-D5B7-4890-9696-410D2EC9647EQ38611191-1C77B85C-C32B-48DA-BABD-81FBA1BA31CAQ38629246-58089FDB-BCD9-4D1B-8296-5A1F54644864Q38630719-94E5A826-6A94-49C2-9348-D24CDBC82F46Q38805641-CBD09EF2-F24A-45AA-B597-02F1163ACF23Q38851480-77FB64E6-82D6-4A80-902B-3A0732419EBAQ38931289-7A8F8A51-8380-488E-85FE-1D74B4A23F01Q39103035-4D4ADFF3-433D-4D20-9876-F19F978E1B63Q39218645-C8B4F361-6AC2-42A8-894F-9C6511D8FACEQ39291741-402046E0-1F0B-476F-BF9E-F1417E8428CAQ39356960-24AF863F-A95E-4D6F-A2F4-B75E63379AEBQ39909074-1B4A417D-5C9A-433A-8C6B-E8FDD84996D3Q41494133-E84FD190-CF3C-42C4-89E2-FDE35F0F2E93Q42135491-15665A12-4CC7-4BD8-A525-137D0055975DQ45902096-43426663-D8D1-4119-9678-2BD58284CA1EQ47213197-5C0C821C-1FBA-4C0D-A2DE-52115FAB4C7EQ47571365-BE7A96A0-1F6C-4E5A-B911-3E8270B9F70FQ47860926-32449784-0E7C-4106-A9B9-F5393E2EF7C9Q48298686-4C40EA66-FA7F-4C14-B7F4-4B9793A6EFEAQ50068847-F0EDEB11-9E62-40BB-B431-53EBAB01E047Q52585556-7979BFFD-C61E-4DEE-B88C-B70B9FE0134AQ54337520-F0217013-BEB3-4BE8-919A-6101504BCD0AQ54966099-1EC1B142-471E-4DC4-9B3D-24CF70659DACQ57478677-80813EF2-E656-4A69-B75F-EA5882A5C449
P2860
In vitro drug causality assessment in Stevens-Johnson syndrome - alternatives for lymphocyte transformation test.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
In vitro drug causality assess ...... ymphocyte transformation test.
@en
In vitro drug causality assess ...... ymphocyte transformation test.
@nl
type
label
In vitro drug causality assess ...... ymphocyte transformation test.
@en
In vitro drug causality assess ...... ymphocyte transformation test.
@nl
prefLabel
In vitro drug causality assess ...... ymphocyte transformation test.
@en
In vitro drug causality assess ...... ymphocyte transformation test.
@nl
P2093
P2860
P356
P1476
In vitro drug causality assess ...... ymphocyte transformation test.
@en
P2093
G Porebski
M Groux-Keller
T Pecaric-Petkovic
T T Kawabata
P2860
P304
P356
10.1111/CEA.12145
P577
2013-09-01T00:00:00Z